A Phase I study of ibrutinib combined with rituximab, ifosfamide, carboplatin, and etoposide in patients with relapsed or primary diffuse large B-cell lymphoma Meeting Abstract


Authors: Sauter, C. S.; Matasar, M. J.; Schoder, H.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Zelenetz, A. D.; McCall, S. S.; Miller, S. T.; Courtien, A. I.; Younes, A.; Moskowitz, C. H.
Abstract Title: A Phase I study of ibrutinib combined with rituximab, ifosfamide, carboplatin, and etoposide in patients with relapsed or primary diffuse large B-cell lymphoma
Meeting Title: 14th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2017 Jun 14-17
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2017-06-07
Start Page: 265
End Page: 266
Language: English
ACCESSION: 123459986
DOI: 10.1002/hon.2438_135
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Meeting Abstract: 275 -- Accession Number: 123459986 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20
Altmetric Score
MSK Authors
  1. Carol Portlock
    181 Portlock
  2. Craig Moskowitz
    375 Moskowitz
  3. Ariela Noy
    208 Noy
  4. Maria Lia Palomba
    128 Palomba
  5. Heiko Schoder
    289 Schoder
  6. Craig Steven Sauter
    167 Sauter
  7. Andrew D Zelenetz
    556 Zelenetz
  8. Matthew J Matasar
    122 Matasar
  9. David J Straus
    213 Straus
  10. Susan J McCall
    14 McCall
  11. Anita Kumar
    52 Kumar
  12. Anas Younes
    203 Younes
  13. Shoshana T Miller
    4 Miller